With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeting the ALT Pathway to Induce Synthetic Lethality and Treat Poor Outcome Pediatric Tumors||University of California, Davis / Wolf-Dietrich Heyer, PhD||Innovation Grants||2018||California|
|Physical Properties of Drug-Resistant Leukemia Cells||Children's Hospital Los Angeles / Yong-mi Kim, MD/PhD||Innovation Grants||2018||California|
|Neighborhood Factors, Acute Kidney Injury and Disparities in Pediatric Acute Myeloid Leukemia||Children's Hospital of Philadelphia / Richard Aplenc, MD/PhD||Epidemiology Grants||2018||Pennsylvania|
|Endocrine Disrupting Pesticides, Neonatal Hormones and Risk of Testicular Germ Cell Tumors||University of California Berkeley / Catherine Metayer, MD, PhD||Epidemiology Grants||2018||California|
|Functional Characterization of RELA Fusion Ependymoma as a Basis for Therapeutic Targeting||Baylor College of Medicine / Stephen Mack, PhD||'A' Award Grants||2018||Texas|
|Mechanisms of PAX3-FOXO1 and HES3 Cooperation in Rhabdomyosarcoma||University of Texas Southwestern Medical Center at Dallas / Genevieve Kendall, PhD||'A' Award Grants||2018||Texas|
|The Role of Pyruvate Dehydrogenase in Leukemia||University of Texas Southwestern Medical Center at Dallas / Michalis Agathocleous, PhD||'A' Award Grants||2018||Texas|
|Epigenetic Targeted Therapy and Resistance in Pediatric Rhabdoid Tumor||Ann & Robert H. Lurie Children's Hospital of Chicago / Rintaro Hashizume, MD/PhD||Reach Grants||2018||Illinois|
|Identifying a Therapeutic Partner for TAK228 for Pediatric Phase II Brain Tumor Studies||The Johns Hopkins University School of Medicine / Eric H. Raabe, MD/PhD||Reach Grants||2018||Maryland|
|Immuno-therapeutic Targeting of CD56 in CBA2T3/GLIS2-AML in Children||Fred Hutchinson Cancer Research Center / Soheil Meshinchi, MD/PhD||Reach Grants||2018||Washington|